vs
富兰克林电气(FELE)与泰尼特医疗(HCSG)财务数据对比。点击上方公司名可切换其他公司
富兰克林电气的季度营收约是泰尼特医疗的1.1倍($500.4M vs $466.7M),富兰克林电气同比增速更快(9.9% vs 6.6%),过去两年泰尼特医疗的营收复合增速更高(5.0% vs -4.0%)
富兰克林电气是全球知名的水务与能源管理产品及系统制造分销商,主营泵类、电机、驱动器及控制设备,产品广泛应用于住宅、商用、农业、工业、市政等多元场景。公司总部位于美国印第安纳州韦恩堡,在美国、德国、捷克、意大利、土耳其、墨西哥、巴西、澳大利亚、南非等多个国家设有生产基地,为全球客户提供可靠的流体运输与能源管理解决方案。
泰尼特医疗集团是一家总部位于达拉斯的美国上市营利性跨国医疗服务企业,旗下通过品牌、子公司、合资企业及合作项目(包括联合外科合作伙伴国际USPI),运营着65家医院与超450家医疗机构,此外还经营康尼弗医疗解决方案,为医疗系统及其他客户提供医疗配套服务支持。
FELE vs HCSG — 直观对比
营收规模更大
FELE
是对方的1.1倍
$466.7M
营收增速更快
FELE
高出3.3%
6.6%
两年增速更快
HCSG
近两年复合增速
-4.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $500.4M | $466.7M |
| 净利润 | $34.7M | — |
| 毛利率 | 35.0% | 15.4% |
| 营业利润率 | 9.6% | 6.1% |
| 净利率 | 6.9% | — |
| 营收同比 | 9.9% | 6.6% |
| 净利润同比 | 10.6% | — |
| 每股收益(稀释后) | $0.77 | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FELE
HCSG
| Q1 26 | $500.4M | — | ||
| Q4 25 | $506.9M | $466.7M | ||
| Q3 25 | $581.7M | $464.3M | ||
| Q2 25 | $587.4M | $458.5M | ||
| Q1 25 | $455.2M | $447.7M | ||
| Q4 24 | $485.7M | $437.8M | ||
| Q3 24 | $531.4M | $428.1M | ||
| Q2 24 | $543.3M | $426.3M |
净利润
FELE
HCSG
| Q1 26 | $34.7M | — | ||
| Q4 25 | $39.3M | — | ||
| Q3 25 | $16.7M | $43.0M | ||
| Q2 25 | $60.1M | $-32.4M | ||
| Q1 25 | $31.0M | $17.2M | ||
| Q4 24 | $33.7M | — | ||
| Q3 24 | $54.6M | $14.0M | ||
| Q2 24 | $59.1M | $-1.8M |
毛利率
FELE
HCSG
| Q1 26 | 35.0% | — | ||
| Q4 25 | 33.8% | 15.4% | ||
| Q3 25 | 35.9% | 20.8% | ||
| Q2 25 | 36.1% | 0.6% | ||
| Q1 25 | 36.0% | 15.2% | ||
| Q4 24 | 33.8% | 13.4% | ||
| Q3 24 | 35.7% | 14.8% | ||
| Q2 24 | 36.8% | 9.7% |
营业利润率
FELE
HCSG
| Q1 26 | 9.6% | — | ||
| Q4 25 | 10.2% | 6.1% | ||
| Q3 25 | 14.6% | 12.3% | ||
| Q2 25 | 15.0% | -9.1% | ||
| Q1 25 | 9.7% | 5.3% | ||
| Q4 24 | 8.9% | 3.4% | ||
| Q3 24 | 13.8% | 4.4% | ||
| Q2 24 | 14.6% | -0.5% |
净利率
FELE
HCSG
| Q1 26 | 6.9% | — | ||
| Q4 25 | 7.7% | — | ||
| Q3 25 | 2.9% | 9.3% | ||
| Q2 25 | 10.2% | -7.1% | ||
| Q1 25 | 6.8% | 3.8% | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 10.3% | 3.3% | ||
| Q2 24 | 10.9% | -0.4% |
每股收益(稀释后)
FELE
HCSG
| Q1 26 | $0.77 | — | ||
| Q4 25 | $0.87 | $0.43 | ||
| Q3 25 | $0.37 | $0.59 | ||
| Q2 25 | $1.31 | $-0.44 | ||
| Q1 25 | $0.67 | $0.23 | ||
| Q4 24 | $0.73 | $0.15 | ||
| Q3 24 | $1.17 | $0.19 | ||
| Q2 24 | $1.26 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $80.4M | $168.0M |
| 总债务越低越好 | $134.4M | — |
| 股东权益账面价值 | $1.3B | $510.2M |
| 总资产 | $2.0B | $794.3M |
| 负债/权益比越低杠杆越低 | 0.10× | — |
8季度趋势,按日历期对齐
现金及短期投资
FELE
HCSG
| Q1 26 | $80.4M | — | ||
| Q4 25 | $99.7M | $168.0M | ||
| Q3 25 | $102.9M | $177.5M | ||
| Q2 25 | $104.6M | $134.5M | ||
| Q1 25 | $84.0M | $114.8M | ||
| Q4 24 | $220.5M | $107.3M | ||
| Q3 24 | $106.3M | $103.8M | ||
| Q2 24 | $58.1M | $105.6M |
总债务
FELE
HCSG
| Q1 26 | $134.4M | — | ||
| Q4 25 | $135.2M | — | ||
| Q3 25 | $135.2M | — | ||
| Q2 25 | $14.5M | — | ||
| Q1 25 | $14.9M | — | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $11.6M | — | ||
| Q2 24 | $87.2M | — |
股东权益
FELE
HCSG
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $510.2M | ||
| Q3 25 | $1.3B | $496.0M | ||
| Q2 25 | $1.3B | $477.0M | ||
| Q1 25 | $1.3B | $514.2M | ||
| Q4 24 | $1.3B | $499.9M | ||
| Q3 24 | $1.3B | $488.7M | ||
| Q2 24 | $1.2B | $471.4M |
总资产
FELE
HCSG
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $794.3M | ||
| Q3 25 | $2.0B | $804.3M | ||
| Q2 25 | $2.0B | $802.2M | ||
| Q1 25 | $1.9B | $823.0M | ||
| Q4 24 | $1.8B | $802.8M | ||
| Q3 24 | $1.8B | $805.8M | ||
| Q2 24 | $1.8B | $799.7M |
负债/权益比
FELE
HCSG
| Q1 26 | 0.10× | — | ||
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $17.4M |
| 自由现金流经营现金流 - 资本支出 | — | $16.0M |
| 自由现金流率自由现金流/营收 | — | 3.4% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $139.2M |
8季度趋势,按日历期对齐
经营现金流
FELE
HCSG
| Q1 26 | — | — | ||
| Q4 25 | $104.2M | $17.4M | ||
| Q3 25 | $102.7M | $71.3M | ||
| Q2 25 | $51.5M | $28.8M | ||
| Q1 25 | $-19.5M | $27.5M | ||
| Q4 24 | $110.3M | $36.2M | ||
| Q3 24 | $116.1M | $4.3M | ||
| Q2 24 | $36.4M | $16.3M |
自由现金流
FELE
HCSG
| Q1 26 | — | — | ||
| Q4 25 | $88.7M | $16.0M | ||
| Q3 25 | $91.3M | $70.0M | ||
| Q2 25 | $39.9M | $27.4M | ||
| Q1 25 | $-26.3M | $25.8M | ||
| Q4 24 | $97.5M | $34.8M | ||
| Q3 24 | $106.6M | $2.9M | ||
| Q2 24 | $26.1M | $15.0M |
自由现金流率
FELE
HCSG
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | 3.4% | ||
| Q3 25 | 15.7% | 15.1% | ||
| Q2 25 | 6.8% | 6.0% | ||
| Q1 25 | -5.8% | 5.8% | ||
| Q4 24 | 20.1% | 7.9% | ||
| Q3 24 | 20.1% | 0.7% | ||
| Q2 24 | 4.8% | 3.5% |
资本支出强度
FELE
HCSG
| Q1 26 | — | — | ||
| Q4 25 | 3.1% | 0.3% | ||
| Q3 25 | 2.0% | 0.3% | ||
| Q2 25 | 2.0% | 0.3% | ||
| Q1 25 | 1.5% | 0.4% | ||
| Q4 24 | 2.6% | 0.3% | ||
| Q3 24 | 1.8% | 0.3% | ||
| Q2 24 | 1.9% | 0.3% |
现金转化率
FELE
HCSG
| Q1 26 | — | — | ||
| Q4 25 | 2.65× | — | ||
| Q3 25 | 6.14× | 1.66× | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | -0.63× | 1.60× | ||
| Q4 24 | 3.28× | — | ||
| Q3 24 | 2.13× | 0.31× | ||
| Q2 24 | 0.62× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FELE
暂无分部数据
HCSG
| Dietary Services | $255.9M | 55% |
| Other | $210.8M | 45% |